证券代码：000638 证券简称：万方发展 公告编号：2023-037 万方城镇投资发展股份有限公司 关于为控股子公司提供担保的公告 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 截止目前，本次被担保对象湖北新瑞光机电科技有限公司的资产负债率超过 70%，敬请投资者注意投资风险。 一、担保情况概述 1、万方城镇投资发展股份有限公司（以下简称"公司"）于近日与航天科工 金融租赁有限公司（以下简称"债权人"）签署了《航天科工金融租赁有限公司保 证合同》（编号：HTJZ-A(BZ)-2023082-1）。根据上述合同约定，公司为控股子公 司湖北新瑞光机电科技有限公司（以下简称"新瑞光"或"债务人"）与债权人 签署的《融资租赁合同》（编号：HTJZ-A(ZZ)-2023082，以下简称"主合同"）提 供连带责任担保，担保金额为人民币 221 万元，保证期间为主合同项下债务人全 部债务履行期限届满之日起三年。 2、公司于 2023 年 6 月 16 日召开 2022 年年度股东大会审议通过了《关于 2023 年度对外担保额度预计的议案》，公司同意为控股子 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥50,029,641.92, a decrease of 13.86% compared to ¥58,080,420.49 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of ¥9,258,850.13, representing a decline of 23.49% from a loss of ¥7,497,597.76 in the previous year[21]. - The basic and diluted earnings per share were both -¥0.0299, a decrease of 23.55% from -¥0.0242 in the same period last year[22]. - The total revenue from military products increased by 49.51% to ¥8,313,222.23, accounting for 16.62% of total revenue[59]. - Revenue from agricultural products processing and sales decreased by 15.79% to ¥41,215,616.89, representing 82.38% of total revenue[59]. - Total operating revenue for the first half of 2023 was CNY 50,029,641.92, a decrease from CNY 58,080,420.49 in the same period of 2022[162]. - Net loss attributable to shareholders of the parent company was CNY 9,258,850.13 for the first half of 2023, compared to a loss of CNY 7,497,597.76 in the same period of 2022[163]. - Total comprehensive income for the first half of 2023 was -11,928,263.21 yuan, compared to -8,264,461.79 yuan in the same period of 2022, representing a decline of approximately 44.5%[164]. Cash Flow and Liquidity - The net cash flow from operating activities improved to -¥25,134,910.60, a 53.24% increase compared to -¥53,755,985.53 in the same period last year[22]. - The company reported a significant increase in cash flow from investing activities, which improved by 71.46% to -¥10,447,844.03 from -¥36,613,056.63[56]. - The company's cash and cash equivalents decreased by 23.02% to -¥73,905,308.38 from -¥96,002,024.72 year-on-year[57]. - The cash inflow from financing activities was primarily due to 496,881.10 CNY received from investment absorption[171]. - The total cash and cash equivalents decreased by 73,905,308.38 CNY in the first half of 2023, compared to a decrease of 96,002,024.72 CNY in the first half of 2022[169]. - The net cash flow from operating activities for the first half of 2023 was -4,751,796.06 CNY, a significant decline compared to 302,678.89 CNY in the same period of 2022[171]. Assets and Liabilities - The total assets at the end of the reporting period were ¥543,967,522.93, down 4.15% from ¥567,518,095.85 at the end of the previous year[22]. - The company's total liabilities decreased from CNY 339,159,439.91 to CNY 320,478,716.89, a reduction of approximately 5.5%[156]. - The company's current assets decreased from CNY 364,934,318.44 to CNY 317,715,432.80, representing a reduction of about 12.9%[155]. - The company's total liabilities as of June 30, 2023, were CNY 169,380,466.43, compared to CNY 162,590,241.93 at the start of the year[160]. Investments and Projects - The company has invested 70% in a project to produce 12,000 tons of astaxanthin annually, with a total investment of 100 million RMB[42]. - The company is focusing on expanding its military sector through the capital increase in Hubei Xinrui Optical Technology Co., Ltd., enhancing its competitive edge in the military field[78]. - The company has signed an investment agreement to increase the registered capital of its subsidiary, New Rui Guang, to 40 million yuan[136]. - The company has made strategic investments to enhance its military industry layout through partnerships with You Lian Chang Xin and Shi Fou Feng Ge[136]. Research and Development - The research and development model includes both customer-driven and self-initiated projects to maintain technological leadership in niche markets[38]. - The company has a robust R&D team with expertise in various biological products, contributing to its innovative production techniques in the health sector[53]. - Research and development expenses rose to CNY 1,459,103.08 in the first half of 2023, compared to CNY 666,471.09 in the same period of 2022[163]. Risk Management - The company faces various operational risks, which are detailed in the report, and emphasizes the importance of risk awareness for investors[6]. - The company faces risks from market competition, particularly in composite materials, and plans to increase product development and market expansion efforts[79]. - The company is also addressing risks from natural disasters by improving infrastructure resilience and utilizing new technologies[80]. Corporate Governance and Shareholder Matters - The company plans not to distribute cash dividends or issue bonus shares for the first half of 2023[86]. - The annual shareholders' meeting on June 16, 2023, had a participation rate of 12.23%[84]. - The company has canceled unexercised stock options from the first exercise period of the 2021 stock option incentive plan, totaling 1,925,449 options[94]. - The company appointed a new deputy general manager, replacing the previous one due to personal reasons on June 19, 2023[85]. Market and Competitive Position - The military business segment focuses on high-silicon aluminum alloys and gradient silicon-aluminum composite materials, contributing to advanced radar and aerospace applications[32]. - The agricultural segment aims to stabilize original grain storage and sales while enhancing brand building and product profitability through technological innovation[39]. - The company is actively collaborating with military clients to expand production capacity and meet customer demands in the military sector[33]. Compliance and Legal Matters - The company has not faced any administrative penalties due to environmental issues during the reporting period[100]. - There were no significant lawsuits or arbitration matters during the reporting period[112]. - The company has not engaged in any related party transactions during the reporting period[113].

公司于2023年8月22日召开第九届董事会第五十二次会议，审议通过了《关 于全资子公司购买债权的议案》，根据深圳证券交易所《股票上市规则》和公司 《对外投资管理办法》的相关规定，本次对外投资事项无需提交股东大会审议批 准。 本次交易不构成关联交易，也不构成《上市公司重大资产重组管理办法》规 定的重大资产重组，无需经有关部门批准。 二、交易双方的基本情况 证券代码：000638 证券简称：万方发展 公告编号：2023-032 万方城镇投资发展股份有限公司 关于全资子公司购买债权的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、概述 2023年8月22日，万方城镇投资发展股份有限公司（以下简称"公司"）全资 子公司吉林万方嘉汇企业运营管理有限公司（以下简称"万方嘉汇"或"受让方"） 与北京辉创思宇商贸有限公司（以下简称"辉创思宇"或"出让方"）签订了《债权 转让协议》，万方嘉汇将出资6,400万元，购买辉创思宇持有的对四川三洲川化机 核能设备制造有限公司（以 ...

万方城镇投资发展股份有限公司（以下简称"公司"）第九届董事会第五十二 次会议通知于 2023 年 8 月 18 日以通讯形式发出，会议于 2023 年 8 月 22 日下 午 14：30 时在北京市朝阳区裕民路 12 号中国国际科技会展中心 B 座 12A 公司 会议室以通讯的方式召开，会议应到董事 9 名，实到 9 名，会议由董事长张晖先 生主持，本次会议召开符合《公司法》及《公司章程》的相关规定。会议审议并 通过了如下议案： 一、以9票同意，0票反对，0票弃权，审议通过了《关于全资子公司购买债 权的议案》。 具体内容详见公司同日在《中国证券报》《证券时报》《上海证券报》《证券 日报》及巨潮资讯网（http://www.cninfo.com.cn）披露的《关于全资子公司购买 债权的公告》（公告编号：2023-032）。 证券代码：000638 证券简称：万方发展 公告编号：2023-031 万方城镇投资发展股份有限公司 第九届董事会第五十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确、完整 ...

证券代码：000638 证券简称：万方发展 万方城镇投资发展股份有限公司 投资者关系活动记录表 编号：2023-001 2、万方发展主要经营什么？ 您好，目前我公司主要业务包括军工产业、农业产业以及生物健康等 相关业务。感谢您的提问，谢谢。 3、为什么不派发现金红利，不送红股？股民一年等一次分红。 您好，感谢您的提问。根据《公司法》和《公司章程》的相关规定， 公司实现的利润应首先用于弥补以前年度亏损，完全弥补以前年度亏 损后才能进行分配。中兴财光华会计师事务所（特殊普通合伙）审计 确认，公司 2022 年度实现归属于母公司所有者净利润 420.12 万元。 截至 2022 年 12 月 31 日，公司合并期末未分配利润-28,303.51 万元， 而截至 2022 年 12 月 31 日，公司母公司期末未分配利润-29,330.50 万 元。 基于以上情况，公司 2022 年度不进行利润分配，亦不进行资本 公积转增股本。公司管理层及下属子公司将通过努力，积极拓展市 场、扩大经营、加大转型力度，竭尽全力提高公司盈利能力。谢谢。 4、董秘您好，我看了贵公司的年报，非常关注贵公司虾青素产业的 发展，公司的虾青素生产 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：000638 证券简称：万方发展 公告编号：2023-016 万方城镇投资发展股份有限公司 关于参加网上集体业绩说明会的公告 董 事 会 二〇二三年五月十二日 1 / 1 特此公告。 万方城镇投资发展股份有限公司 为进一步加强与投资者的互动交流，万方城镇投资发展股份有限公司（以下 简称"公司"）将参加由吉林证监局、吉林省证券业协会、深圳市全景网络有限 公司共同举办的"2023 年吉林辖区上市公司网上集体业绩说明会"，现将有关事 项公告如下： 本次集体业绩说明会将通过深圳市全景网络有限公司提供的互联网平台举 行，投资者可以登陆"全景网"投资者关系互动平台"（http://ir.p5w.net）参与公 司业绩说明会，时间为 2023 年 5 月 22 日（星期一）14:00 至 16:00。 届时公司董事兼总经理章寒晖先生，董事、常务副总经理兼董事会秘书郭子 斌女士，财务总监谌志旺先生将通过网络在线问答互动的形式，与投资者就 2022 年经营业绩等投资者关注的问题进行交流。期间，公司高管将全程在线，实时回 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥36,657,977.24, representing a 27.05% increase compared to ¥28,853,677.06 in the same period last year[5] - The net loss attributable to shareholders was ¥3,679,649.02, a 12.08% improvement from a loss of ¥4,185,069.86 in the previous year[5] - The basic and diluted earnings per share were both -¥0.0119, showing an 11.85% improvement from -¥0.0135 in the previous year[5] - Net loss for Q1 2023 was CNY 4,187,955.96, compared to a net loss of CNY 4,432,439.88 in Q1 2022, showing a slight improvement[23] - The total comprehensive income for the period was -4,232,170.28 yuan, compared to -4,432,439.88 yuan in the previous period, showing an improvement of approximately 4.5%[24] Cash Flow - The net cash flow from operating activities improved by 54.11%, amounting to -¥25,124,379.37 compared to -¥54,751,275.39 in the same period last year[5] - The net cash flow from operating activities was -25,124,379.37 yuan, an improvement from -54,751,275.39 yuan in the previous period, indicating a reduction in cash outflow of about 54.2%[27] - Cash inflow from sales of goods and services was 28,254,354.18 yuan, up from 18,054,927.23 yuan, representing a growth of approximately 56.5%[26] - The net cash flow from investing activities was -1,622,320.00 yuan, compared to -32,747,918.63 yuan in the previous period, reflecting a significant reduction in cash outflow of about 95.0%[27] - The net cash flow from financing activities was 3,699,378.75 yuan, a recovery from -6,458,670.84 yuan in the previous period, indicating a turnaround in financing cash flow[27] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥551,671,427.00, a decrease of 2.79% from ¥567,518,095.85 at the end of the previous year[5] - The company's total assets decreased to CNY 551,671,427.00 from CNY 567,518,095.85 at the beginning of the year, a decline of 2.5%[22] - Current liabilities decreased to CNY 307,041,602.72 from CNY 327,076,355.21, a reduction of 6.1%[22] - The total owner's equity decreased to CNY 224,456,814.85 from CNY 228,358,655.94, a decline of 1.7%[22] Investments and Expenditures - The company's investment income for the period was -¥16,950.00[12] - The cash flow from investing activities was -¥162,230.00, mainly due to the acquisition of long-term assets[14] - The company reported an increase in development expenditures to CNY 1,403,991.69 from CNY 729,467.08, indicating a focus on new product development[22] - Long-term equity investments slightly decreased to CNY 59,917,415.62 from CNY 60,086,942.56, a decline of 0.3%[22] Government Support and Tax - The company received government subsidies amounting to ¥2,216,355.82, primarily from its subsidiary Harbin Zhuding Gongda New Materials Technology Co., Ltd.[7] - The company received 170,612.32 yuan in tax refunds, up from 12,075.27 yuan, indicating a significant increase in tax-related cash inflows[26] Financial Expenses - The company's financial expenses for Q1 2023 were CNY 1,292,801.46, down from CNY 1,490,998.99 in the previous year[23] - The cash outflow for employee compensation was 4,413,716.48 yuan, slightly decreased from 4,710,622.96 yuan in the previous period[27] Consistency in Performance - The company did not report any net profit from merged entities during the current and previous periods, maintaining a consistent performance in this area[24]

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2022, representing a year-on-year increase of 15%[15]. - The net profit attributable to shareholders was 200 million RMB, which is a decrease of 10% compared to the previous year[15]. - The company's operating revenue for 2022 was ¥157.71 million, a decrease of 51.09% compared to ¥322.43 million in 2021[22]. - The net profit attributable to shareholders for 2022 was ¥4.20 million, down 93.09% from ¥60.84 million in 2021[22]. - The company reported a quarterly revenue of ¥51.24 million in Q4 2022, showing a significant increase compared to previous quarters[27]. - The net profit attributable to shareholders in Q4 2022 was ¥11.05 million, marking a recovery from losses in earlier quarters[27]. - The company achieved a total operating revenue of ¥157,707,909.65, a decrease of 51.09% compared to the previous year[60]. - The net profit attributable to the parent company was ¥4,201,241.96, down 93.09% year-on-year[60]. - Revenue from military products was ¥30,720,182.34, down 53.54% from ¥66,126,629.56 in 2021, with a gross margin of 49.23%[69]. - Revenue from agricultural product processing and sales increased by 22.70% to ¥119,486,289.06, with a gross margin of 12.92%[69]. User Engagement and Market Expansion - User data showed an increase in active users by 25%, reaching a total of 5 million users by the end of 2022[15]. - The company plans to expand its market presence in three new provinces, aiming for a 30% increase in market share by 2024[15]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share within the next two years[98]. - The company provided guidance for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion, driven by new product launches and market expansion[98]. Research and Development - The company has allocated 50 million RMB for research and development in new technologies for urban infrastructure[15]. - Research and development expenses amounted to ¥3,582,789.59, with capitalized R&D costs of ¥2,584,556.76 primarily from the subsidiary[62]. - R&D investment accounted for 2.27% of operating revenue in 2022, up from 1.66% in 2021, an increase of 0.61%[79]. - The company is committed to independent research and development to maintain its leading technological position in the industry[43]. - The company is focused on developing new products in the fields of biological feed and organic fertilizers, aiming to enhance its market offerings[99]. Strategic Investments and Acquisitions - The company is exploring potential mergers and acquisitions to enhance its service offerings and market reach[15]. - A strategic acquisition was completed, adding 50 million in annual revenue and expanding the company's product portfolio[98]. - The company acquired a 51.01% stake in a biomedical company for ¥21,000,000, enhancing its presence in the medical equipment sector[92]. - The company is actively pursuing mergers and acquisitions to strengthen its market position and diversify its portfolio[92]. - The company plans to establish a holding subsidiary as part of its investment strategy, approved on November 21, 2022[163]. Operational Efficiency and Cost Management - Operating margin improved to 20%, up from 18% in the previous year, reflecting better cost management and operational efficiency[98]. - The company has outlined future growth strategies that include enhancing operational efficiency and expanding into new markets[92]. - The company plans to enhance its operational strategy by expanding horizontally and vertically while improving internal controls[44]. Agricultural Focus - The agricultural sector is expected to grow, with the company focusing on modern agricultural practices and achieving a record grain output of over 140 million tons in 2022[34]. - The company has established a wholly-owned subsidiary in Baishan City to develop agricultural business, aiming to expand its product offerings beyond rice to include local agricultural products[47]. - The company is focused on expanding its agricultural production services and management activities[95]. - The company is advancing its astaxanthin project in Baishan City, aiming for rapid construction and mass production, with a focus on developing a complete astaxanthin industry chain[113]. Governance and Management - The company has established independent organizational structures that function separately from the controlling shareholder[130]. - The company has a diverse board of directors, including independent directors, ensuring governance and oversight[135]. - The company is committed to transparency and has disclosed all relevant information regarding board member changes and shareholder meetings[136]. - The company has undergone significant management changes, with multiple appointments and resignations in early 2022, indicating a potential shift in strategic direction[137]. - The company is focused on strengthening its governance structure through the appointment of qualified independent directors[146]. Environmental Responsibility - The company and its subsidiaries are not classified as key pollutant discharge units by environmental protection authorities[199]. - There were no administrative penalties due to environmental issues during the reporting period[199]. - The company has implemented measures to reduce carbon emissions, although specific details were not disclosed[200].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥58,080,420.49, a decrease of 26.32% compared to ¥78,825,016.48 in the same period last year[20]. - The net profit attributable to shareholders was a loss of ¥7,497,597.76, representing a decline of 172.64% from a profit of ¥10,321,115.30 in the previous year[20]. - The net cash flow from operating activities was negative at ¥53,755,985.53, which is a 40.74% increase in cash outflow compared to ¥38,195,209.85 in the same period last year[20]. - The basic and diluted earnings per share were both -¥0.0242, down 172.46% from ¥0.0334 in the previous year[20]. - The company's revenue for the reporting period was ¥58,080,420.49, a decrease of 26.32% compared to ¥78,825,016.48 in the same period last year, primarily due to severe domestic pandemic conditions[51]. - The company reported a significant decrease in revenue from military products, down 78.96% to ¥5,560,282.58, compared to ¥26,433,033.56 in the previous year[54]. - Revenue from grain processing and sales surged by 253.33% to ¥48,943,566.96, up from ¥13,852,158.89 year-on-year[54]. - The company's total operating revenue for the first half of 2022 was ¥58,080,420.49, a decrease of 26.32% compared to ¥78,825,016.48 in the same period last year[54]. - The net profit for the first half of 2022 was a loss of ¥8,162,077.01, compared to a profit of ¥10,766,780.60 in the first half of 2021[193]. - The total comprehensive income for the first half of 2022 was a loss of ¥8,264,461.79, contrasting with a profit of ¥10,766,780.60 in the first half of 2021[193]. Assets and Liabilities - The total assets at the end of the reporting period were ¥493,037,754.07, a decrease of 12.23% from ¥561,721,695.91 at the end of the previous year[20]. - The net assets attributable to shareholders decreased by 9.84% to ¥157,861,192.92 from ¥175,080,444.32 at the end of the previous year[20]. - The company's cash and cash equivalents decreased significantly by 354.80% to -¥96,002,024.72 from -¥21,108,730.70 in the previous year[52]. - The company's total assets included cash of ¥26,944,772.34, which accounted for 5.47% of total assets, down from 21.89% the previous year[60]. - The company's total assets amount to 16,244.54 million, with net assets of 7,285.58 million[76]. - The company's total liabilities decreased to CNY 275,696,615.54 from CNY 320,842,975.67, a decline of around 14.0%[185]. - The owner's equity decreased to CNY 217,341,138.53 from CNY 240,878,720.24, representing a decrease of about 9.8%[185]. Operational Challenges and Strategies - The company faced significant operational challenges leading to a negative return on equity of -4.33%, down from 9.02% in the previous year[20]. - The company has outlined risks and countermeasures in its management discussion, emphasizing the need for strategic adjustments in response to market conditions[5]. - In the first half of 2022, the company focused on optimizing asset allocation and improving operational efficiency amid ongoing domestic pandemic impacts and economic pressures[28]. - The company’s military and agricultural businesses have not yet stabilized, affecting its operational resilience[83]. - The company faced risks due to macroeconomic fluctuations and COVID-19 policies, which disrupted supply chains and impacted financial performance[77]. Research and Development - The R&D team is led by Professor Xing Dawei, who has extensive experience in new materials development and has participated in several national research projects[41]. - The company has applied for multiple patents related to new material preparation technologies, with 3 invention patents and 1 utility model already authorized[45]. - The company aims to enhance its R&D capabilities and expand its product offerings in the biopharmaceutical sector, striving to become a comprehensive entity in vaccine development and production[49]. - The company is focusing on the agricultural sector through its subsidiary, WanFang MaiJie, which aims to integrate high-tech elements into rural logistics to enhance efficiency and support local economic development[47]. Investments and Subsidiaries - The company has completed an investment of 21 million in Wanfang Bio, acquiring a 51.01% stake[65]. - The company has established a new agricultural technology venture with an investment of 10 million, holding a 100% stake[65]. - The company is involved in various sectors including medical research, health consulting, and sales of medical devices[65]. - The company’s subsidiary, Wanfang Bai'ao, signed a framework agreement to acquire at least 15% of the equity of Yadong Biological (Anguo) for an initial payment of RMB 30 million, with adjustments made to the counterparties involved in the transaction[158]. - The company invested in 24% equity of Weihai Dongxun Biotechnology Co., which specializes in the research, manufacturing, and sales of natural astaxanthin, a product used as an additive in aquaculture feed[159]. Shareholder and Governance Commitments - The company emphasizes the protection of shareholder and creditor rights by ensuring accurate and complete information disclosure[98]. - The company has committed to maintaining the independence of its operations, ensuring that its assets are fully under its control and not misused by other entities[115]. - The company guarantees that its financial department operates independently, with a separate accounting system and bank accounts, ensuring no shared financial resources with other controlled entities[115]. - The company has committed to not using the assets of the listed company to provide guarantees for debts of its controlled enterprises[123]. - The company has pledged to maintain independent operations, ensuring that its assets, personnel, and qualifications are not interfered with by its controlling entities[123]. Financial Support and Future Plans - Huide Industrial committed to provide no less than 200 million CNY in funding support to improve the financial condition and liquidity of the listed company and its subsidiaries[105]. - The company plans to provide at least 58 million CNY for agricultural subsidiary Wan Fang Mai Jie for agricultural product processing and sales, and grain storage[107]. - The company plans to propose a private placement within 6 months after resuming listing, aiming to inject all relevant operational assets in real estate development to enhance sustainable profitability[127]. - The controlling shareholder, Huide Industrial, has delayed the implementation of its financial support plan, which includes a commitment to sign a debt transfer cooperation agreement by June 30, 2022, and to release RMB 57 million in funds by April 30, 2022, based on the company's operational needs[157].

2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信 息的真实、准确、完整。 3.第一季度报告是否经过审计 证券代码：000638 证券简称：*ST 万方 公告编号：2022-038 万方城镇投资发展股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 □ 是 √ 否 万方城镇投资发展股份有限公司 2022 年第一季度报告全文 万方城镇投资发展股份有限公司 2022 年第一季度报告全文 单位：元 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 28,853,677.06 | 30,359,764.25 | -4.96% | | 归属于上市公司股东的净利润（元） | -4,185,0 ...